Ad is loading...
GAHPX
Price
$23.69
Change
-$0.07 (-0.29%)
Updated
Nov 15 closing price
RNWFX
Price
$80.56
Change
-$0.79 (-0.97%)
Updated
Nov 15 closing price
Ad is loading...

GAHPX vs RNWFX

Header iconGAHPX vs RNWFX Comparison
Open Charts GAHPX vs RNWFXBanner chart's image
Goldman Sachs Emerging Markets Eq P
Price$23.69
Change-$0.07 (-0.29%)
VolumeN/A
CapitalizationN/A
American Funds New World R5
Price$80.56
Change-$0.79 (-0.97%)
VolumeN/A
CapitalizationN/A
GAHPX vs RNWFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAHPX vs. RNWFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAHPX is a StrongBuy and RNWFX is a Buy.

FUNDAMENTALS
Fundamentals
RNWFX has more cash in the bank: 60.9B vs. GAHPX (2.77B). RNWFX pays higher dividends than GAHPX: RNWFX (1.51) vs GAHPX (1.28). GAHPX was incepted earlier than RNWFX: GAHPX (7 years) vs RNWFX (23 years). GAHPX (32.00) and RNWFX (32.00) have comparable annual turnover. GAHPX has a lower initial minimum investment than RNWFX: GAHPX (0) vs RNWFX (250). GAHPX annual gain was more profitable for investors over the last year : 13.21 vs. RNWFX (11.54). RNWFX return over 5 years is better than : 17.17 vs. GAHPX (10.70).
GAHPXRNWFXGAHPX / RNWFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years23 years-
Gain YTD10.0337.099141%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.77B60.9B5%
Annual Yield % from dividends1.281.5185%
Returns for 1 year13.2111.54114%
Returns for 3 years-22.98-14.55158%
Returns for 5 years10.7017.1762%
Returns for 10 yearsN/A41.00-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRNA35.660.29
+0.82%
Verona Pharma plc
BURL268.94-0.65
-0.24%
Burlington Stores
RCMT22.25-0.38
-1.68%
RCM Technologies
SNTI2.15-0.18
-7.73%
Senti Biosciences Inc.
CATX7.88-1.04
-11.66%
Perspective Therapeutics